Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 2 Open-label Study of Loncastuximab Tesirine in Combination with Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Patients with Diffuse Large B-cell Lymphoma (DLBCL) (LOTIS-9)
Sponsored by Pharmaceutical Research Associates
$188.6K Funding
4 People
External
Related Topics
lymphoma,
cancer treatment,
immunotherapy,
clinical trial,
drug combination
People
Carolyn Lane
(CD)
Cancer Center Division
﹒Research Laboratory Manager I
Lora Inclan
(CD)
Cancer Center Division
﹒Clinical Research Coordinator III
Sandra Ortega
(CD)
Cancer Center Division
﹒Clinical Research Coordinator II
Brianna Denton
(CD)
Cancer Center Division
﹒Research Compliance Manager I
